However, in angioimmunoblastic T-cell lymphoma, sometimes activated B lymphocytes may be visualized as CD30-positive through FCM; hence, a comprehensive decision is required by combining cellular imaging and immunohistochemistry for T antigens. The gene discussed is TNFRSF8; the disease is angioimmunoblastic T-cell lymphoma.